Check Your Claims Before Reviewers Do

 Quick Explanation Copied

 Long Explanation

Citation Metrics and Research Trajectory

Rabia Liamlahi (ORCID 0000-0003-4340-4630) shows two consistent metric profiles: Semantic Scholar reports h-index 13, 596 citations, 33 papers, while OpenAlex reports h-index 16, 913 citations across 44 works. The discrepancy likely reflects different paper-matching and self-citation handling between databases, a known source of metric variance.

Her publication record clusters into two well-defined programs: (1) neurodevelopmental, neuroimaging, and outcome research in children with congenital heart disease (CHD), including hypoplastic left heart syndrome surgical comparisons, cerebral MRI correlates, hippocampal volume studies, and pooled longitudinal cohorts into adulthood; and (2) anesthesiology-focused gastric emptying and fasting studies in children using MRI and ultrasound.

Key Contributions

Her most cited works are all CHD neurodevelopment papers from the Zurich group: the 2015 Journal of Pediatrics study showing severe congenital heart defects associate with globally reduced neonatal brain volumes (134 citations), the 2017 school-age neurodevelopmental profiles paper (83 citations), and the 2012 hybrid vs. Norwood procedure comparison in HLHS (68 citations). She also authored a Handbook of Clinical Neurology chapter on CHD neurodevelopmental outcomes (65 citations) as first author, indicating recognized synthesis expertise in her niche.

Neonatal brain volume reduction in severe CHD

School-age CHD neurodevelopmental profiles

Critical Assessment

Strengths: Sustained longitudinal follow-up of a well-characterized CHD cohort from infancy into adolescence/adulthood is methodologically demanding and clinically valuable. Multi-modal assessment (MRI, DTI, sleep EEG, HRV, neuropsychological testing) and recent expansion into novel biomarkers (fecal melatonin, gut microbiota) show adaptive scientific thinking.

Limitations: She is overwhelmingly a middle author on collaborative papers; first/last authorship is limited, suggesting she functions primarily as a contributor within Beatrice Latal's group rather than as an independent PI. Work is single-center (Zurich), limiting generalizability. Citation density is strong for 2011–2017 but declines after 2018 (works fell to 1–3/year), with 2026 showing 10 works but only 3 citations so far — metrics too immature to judge. Small cohort sizes typical of rare CHD populations constrain statistical power, a known limitation in this field.

Confidence note: Assessment rests on bibliometric metadata and titles/abstracts only, not full-text quality appraisal; affiliation data are inconsistent (Boston Children's vs. University Children's Hospital Zurich listings), so institutional history is uncertain.

 BGPT Author Review

Scientific Quality

Solid clinical researcher embedded in a productive Zurich pediatric neurodevelopment group; h-index 13–16 and ~600–900 citations are respectable for clinical pediatrics but reflect team science rather than independent leadership. First-author works include a Handbook of Clinical Neurology chapter and cohort papers, but most high-impact contributions are middle-authored. Sustained cohort follow-up into adulthood is a genuine strength; single-center scope and modest recent output are weaknesses.

Communication Quality

Titles are clear, descriptive, and standard for clinical literature; the Handbook chapter indicates ability to synthesize a field. No evidence of exceptional science communication (no visible reviews in broad venues or public-facing work), so score is moderate based on typical clinical paper conventions.

Author Novelty

Work is incremental but rigorous: applying established neuroimaging and neuropsychological methods to a rare CHD cohort. Recent pivot to fecal melatonin/gut microbiota biomarkers in infancy is a fresh direction; the fasting-MRI studies were practically influential for perioperative guidelines but conceptually conventional.

Scientific Rigor

Prospective longitudinal designs, multi-modal measures, and pooled analyses suggest above-average rigor; publication in J Pediatrics, BJA, and EJCTS supports quality. However, rare-disease cohorts are inherently small, single-center, and vulnerable to selection/attrition bias; no evidence of pre-registration or independent replication from the available metadata.